Liu KSH - Search Results

1

A Territorywide Prevalence Study on Blood-Borne and Enteric Viral Hepatitis in Hong Kong.

Liu KSH, Seto WK, Lau EHY, Wong DK, Lam YF, Cheung KS, Mak LY, Ko KL, To WP, Law MWK, Wu JT, Lai CL, Yuen MF. Liu KSH, et al. J Infect Dis. 2019 May 24;219(12):1924-1933. doi: 10.1093/infdis/jiz038. J Infect Dis. 2019. PMID: 30668746

2

Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation.

Seto WK, Liu KS, Mak LY, Cloherty G, Wong DK, Gersch J, Lam YF, Cheung KS, Chow N, Ko KL, To WP, Fung J, Yuen MF. Seto WK, et al. Gut. 2021 Apr;70(4):775-783. doi: 10.1136/gutjnl-2020-321116. Epub 2020 Aug 5. Gut. 2021. PMID: 32759300

3

Factors for hepatitis B vaccination and abnormal liver function in Chinese patients with inflammatory bowel disease: a single center experience.

Leung WK, Liu KSh, Seto WK, Chan KH, Tong T, Yuen MF, Lai CL, Hung IF. Leung WK, et al. Among authors: liu ksh. J Dig Dis. 2013 Nov;14(11):596-603. doi: 10.1111/1751-2980.12089. J Dig Dis. 2013. PMID: 23870196

4

Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re-evaluation of HBsAg seroclearance.

Seto WK, Tanaka Y, Wong DK, Shinkai N, Cheung KS, Liu KS, Fung J, Lai CL, Yuen MF. Seto WK, et al. Liver Int. 2016 May;36(5):642-50. doi: 10.1111/liv.12980. Epub 2015 Nov 5. Liver Int. 2016. PMID: 26474013

5

Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.

Seto WK, Hui RWH, Mak LY, Fung J, Cheung KS, Liu KSH, Wong DK, Lai CL, Yuen MF. Seto WK, et al. Among authors: liu ksh. Clin Gastroenterol Hepatol. 2018 Apr;16(4):575-583.e2. doi: 10.1016/j.cgh.2017.09.044. Epub 2017 Sep 29. Clin Gastroenterol Hepatol. 2018. PMID: 28970146

6

Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment.

Seto WK, Liu K, Wong DK, Fung J, Huang FY, Hung IF, Lai CL, Yuen MF. Seto WK, et al. J Hepatol. 2013 Oct;59(4):709-16. doi: 10.1016/j.jhep.2013.06.007. Epub 2013 Jun 17. J Hepatol. 2013. PMID: 23792029

7

Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir.

Seto WK, Liu K, Fung J, Wong DK, Yuen JC, Hung IF, Lai CL, Yuen MF. Seto WK, et al. Antivir Ther. 2012;17(7):1255-62. doi: 10.3851/IMP2335. Epub 2012 Sep 6. Antivir Ther. 2012. PMID: 22951420

8

Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.

Tan VP, Liu KS, Lam FY, Hung IF, Yuen MF, Leung WK. Tan VP, et al. Aliment Pharmacol Ther. 2017 Mar;45(6):767-776. doi: 10.1111/apt.13945. Epub 2017 Jan 23. Aliment Pharmacol Ther. 2017. PMID: 28112426 Clinical Trial.

9

Prevention of post-sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial.

Leung WK, But DY, Wong SY, Tong TS, Liu KS, Cheung KS, Tsang SH, Chok KS, Poon RT, Hung IF. Leung WK, et al. J Dig Dis. 2018 Jun;19(6):369-376. doi: 10.1111/1751-2980.12604. Epub 2018 May 24. J Dig Dis. 2018. PMID: 29722146 Clinical Trial.

10

Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment.

Yap DYH, Liu KSH, Hsu YC, Wong GLH, Tsai MC, Chen CH, Hsu CS, Hui YT, Li MKK, Liu CH, Kan YM, Yu ML, Yuen MF. Yap DYH, et al. Among authors: liu ksh. Clin Mol Hepatol. 2020 Oct;26(4):554-561. doi: 10.3350/cmh.2020.0058. Epub 2020 Aug 28. Clin Mol Hepatol. 2020. PMID: 32854457 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters